Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Affymetrix
12%
Age Score
12%
Automated Image Analysis
12%
Biological Variability
12%
CASP4
25%
Cluster of Differentiation 44 (CD44)
25%
COL5A1
25%
COL6A2
25%
Cox Proportional Hazards Model
12%
ECM-receptor Interaction
12%
Edema
12%
Enhancing Tumor
100%
Focal Adhesion
12%
G-CIMP
12%
Gene Age
25%
Gene Expression
100%
Gene Expression Biomarkers
12%
Gene Expression Data
12%
Gene Probes
37%
Glioblastoma multiforme
100%
HCP5
25%
IL10RB
37%
Image Analysis Technique
12%
Imaging Parameters
12%
Inflammation Pathway
12%
Initial Diagnosis
12%
Interleukin-15 (IL-15)
25%
Isocitrate Dehydrogenase 1 (IDH1)
12%
Karnofsky Performance Status
12%
Living Patients
12%
Log-rank Test
25%
LY75
12%
Lysyl Oxidase
37%
Multiple Comparisons
12%
Necrosis
62%
Overall Survival
37%
Pentraxin 3 (PTX3)
25%
Personalized Medicine
12%
Predictive Biomarker
12%
Prognosis Survival
12%
Prognostic Biomarker
100%
Prognostic Significance
12%
Progression-free Survival
100%
Quantitative Imaging
100%
Quantitative Imaging Biomarkers
12%
SLC16A3
25%
Stanniocalcin-1
37%
Survival Prognosis
12%
T-test
12%
Total Tumor Load
25%
Tumor Measurement
12%
Tumor Volume
12%
Medicine and Dentistry
Biological Marker
100%
Cytokine
8%
Edema
8%
Focal Adhesion
8%
Gene Expression
100%
Glioblastoma
100%
HCP5
16%
Image Analysis
8%
Karnofsky Performance Status
8%
Log Rank Test
16%
Necrosis
41%
Neoplasm
100%
Overall Survival
25%
Personalized Medicine
8%
Progression Free Survival
100%
Proportional Hazards Model
8%
Quantitative Imaging
100%
Receptor
8%
Student T Test
8%
The Cancer Genome Atlas
8%
Neuroscience
CD44
40%
Cytokine
20%
Focal Adhesion
20%
Gene Expression
100%
Glioblastoma Multiforme
100%
Necrosis
100%
Quantitative Imaging
100%
Receptor
20%
Biochemistry, Genetics and Molecular Biology
CD44
25%
COL6A2
25%
Cytokine
12%
Focal Adhesion
12%
Gene Expression
100%
Gene Expression Data
12%
Gene Probe
37%
HCP5
25%
IDH1
12%
LY75
12%
Overall Survival
37%
Progression Free Survival
100%
PTX3
25%
STC1
37%
Tumor Volume
25%